GB8701691D0 - Detection of cardiac damage - Google Patents

Detection of cardiac damage

Info

Publication number
GB8701691D0
GB8701691D0 GB878701691A GB8701691A GB8701691D0 GB 8701691 D0 GB8701691 D0 GB 8701691D0 GB 878701691 A GB878701691 A GB 878701691A GB 8701691 A GB8701691 A GB 8701691A GB 8701691 D0 GB8701691 D0 GB 8701691D0
Authority
GB
United Kingdom
Prior art keywords
detection
cardiac damage
cardiac
damage
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
GB878701691A
Other versions
GB2200358B (en
GB2200358A (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Birmingham
Original Assignee
University of Birmingham
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Birmingham filed Critical University of Birmingham
Priority to GB8701691A priority Critical patent/GB2200358B/en
Publication of GB8701691D0 publication Critical patent/GB8701691D0/en
Publication of GB2200358A publication Critical patent/GB2200358A/en
Application granted granted Critical
Publication of GB2200358B publication Critical patent/GB2200358B/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/10—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
    • A61K51/1018—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/10—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
    • A61K51/1093—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody conjugates with carriers being antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6887—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids from muscle, cartilage or connective tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00—Preparations for testing in vivo
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Organic Chemistry (AREA)
  • Optics & Photonics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Food Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
GB8701691A 1987-01-27 1987-01-27 Materials for in vivo detection of cardiac damage, and methods for their preparation Expired - Lifetime GB2200358B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB8701691A GB2200358B (en) 1987-01-27 1987-01-27 Materials for in vivo detection of cardiac damage, and methods for their preparation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8701691A GB2200358B (en) 1987-01-27 1987-01-27 Materials for in vivo detection of cardiac damage, and methods for their preparation

Publications (3)

Publication Number Publication Date
GB8701691D0 true GB8701691D0 (en) 1987-03-04
GB2200358A GB2200358A (en) 1988-08-03
GB2200358B GB2200358B (en) 1991-02-27

Family

ID=10611246

Family Applications (1)

Application Number Title Priority Date Filing Date
GB8701691A Expired - Lifetime GB2200358B (en) 1987-01-27 1987-01-27 Materials for in vivo detection of cardiac damage, and methods for their preparation

Country Status (1)

Country Link
GB (1) GB2200358B (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4243648A1 (en) * 1992-12-23 1994-07-07 Boehringer Mannheim Gmbh Method for the determination of myocardial necrosis by means of antibodies against the N-terminal troponin I peptide
DE69420556T2 (en) * 1993-05-17 2000-03-23 Fortron Bioscience Inc ASSAY FOR TROPONIN I FROM THE HEART MUSCLE
CA2130280C (en) * 1993-08-24 1999-08-31 Lilian Lee Method for purification of cardiac troponin i
AU3483395A (en) * 1994-09-28 1996-04-19 Spectral Diagnostics Inc. A monoclonal antibody to human cardiac troponin i
US6248869B1 (en) 1997-05-29 2001-06-19 Medical Analysis Systems, Inc. Troponin I forms and use of the same
EP2532748B1 (en) 2011-06-07 2014-10-08 Postech Academy-industry Foundation DNA aptamer specifically binding to human cardiac troponin I
CN106198997B (en) * 2016-06-28 2017-07-28 广州华弘生物科技有限公司 A kind of kit of Quantitative detection troponin and creatine kinase isozyme

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6028998A (en) * 1983-07-06 1985-02-14 Yamasa Shoyu Co Ltd Monoclonal antibody to heavy chain of myocardial myosine

Also Published As

Publication number Publication date
GB2200358B (en) 1991-02-27
GB2200358A (en) 1988-08-03

Similar Documents

Publication Publication Date Title
ZA907547B (en) Measurement of cardiac performance
EP0299338A3 (en) Defibrillator
PH23868A (en) Quinolone cardiac stimulants
GB8703228D0 (en) Positional detection of objects
GB8701691D0 (en) Detection of cardiac damage
GR861425B (en) Tetrahydroimidazoquinazolinone cardiac stimulants
YU146288A (en) Derivatives of benzimidazole-2-il-pyridinium
ZA872051B (en) Detection of fungi
GB2217729B (en) Obtenation of scualane
GB8619902D0 (en) Quinolone cardiac stimulants
GB8514207D0 (en) Cardiac stimulants
YU131988A (en) Heart
GB8716395D0 (en) Cardiac pacemakers
GB8619006D0 (en) Positional detection of objects
GB8727215D0 (en) Detection of objects
GB2197347B (en) Heat-treatment of small parts
GB8627670D0 (en) Detection of objects
GB8717741D0 (en) Positional detection of objects
IL83714A0 (en) Detection of malignancies
GB8717997D0 (en) Derivatives of benzoyloxyacetic acid
GB8629748D0 (en) Detection of diseases
HK1021820A1 (en) Derivatives of n-phenylpyrazoles
IE872181L (en) Quinolone cardiac stimulants
IE863125L (en) Quinolone cardiac stimulants
GB8712517D0 (en) Monitoring effects of loading on structures

Legal Events

Date Code Title Description
PCNP Patent ceased through non-payment of renewal fee

Effective date: 19960127